Calmosine Breastfeeding – 2019 Study
Breastfeeding is the most natural thing in the world, however for some mothers the journey is not always easy and both help and support are key to facilitate longer term success.
In 2015 Labarotoires Laudavie launched a new breastfeeding supplement for mothers to take to help them during those first few weeks after they have had their baby. In 2019 in partnership with the Institut de Mamans, they conducted a home-based study to look at the effects of Calmosine Breastfeeding in those mothers who were finding breastfeeding challenging.
Calmosine Breastfeeding is a dietary supplement whose innovative formula (based on natural plant extracts, magnesium and vitamin B8) was developed in collaboration with midwives, lactation consultants, mothers and pharmacists.
Context and selection criteria
The effects of Calmosine Breastfeeding were tested in 60 mothers of a child aged 0 to 8 weeks (on average 25.9 days) and practicing exclusive (82%) or mixed breastfeeding. They were most often parents to more than one child (61.7%) and in couples (95%). More than 8 in 10 (85%) wanted to continue breastfeeding their child for at least 3 months and 15% for 1 to 2 months. One of the recruitment criteria was to agree to continue to breastfeed for at least 1 month after the questionnaire was answered.
Other criteria taken into account for the selection of mothers included their perception of the level of milk produced, the level of fatigue, breastfeeding difficulties and / or the quality of their mood. The importance of these last three parameters was estimated on a scale of 1 to 10.
The Calmosine Breastfeeding study consisted of the administration of one or two pods per day for two weeks, at home. The mothers answered two self-administered questionnaires online, the first after a week and the second after two weeks of treatment.
Before starting the treatment, 98% of the participants had received breastfeeding advice. Midwives were consulted in 43.3% of cases.
Fatigue was a condition shared by the vast majority of mothers before starting the study: 93.3% of them gave a grade ≤ 6 to their level of fatigue 0 being very tired and 10 not at all tired. More than two-thirds (65.5%) expressed the same conclusion when qualifying the quality of their mood. Breastfeeding difficulties were reported by 43.3% of mothers. Almost a quarter (23.3%) believed that their level of milk was “insufficient”.
8 out of 10 mothers felt there was an improvement in their breastfeeding
The average duration of use of the product was 13.5 days. An improvement in the quality of breastfeeding was noted throughout the 2-week study. This is reflected in particular by a signiﬁcant increase in scores to 9 and 10 (+ 16.7%) and a drop in scores ≤ to 6 (-23%) after two weeks of taking the supplement in comparison to scores before starting to use the product.
Overall, more than 8 out of 10 mothers report breastfeeding benefits from the first week of treatment. Regarding lactation, more than three-quarters of mothers (78%) reported an increase in milk production, although the level of milk was not considered too abundant (Figure 1).
Figure One: beneficial effect on milk production
Reduced fatigue and better mood
Each of the parameters evaluated in the study showed improvement, with more marked results on the perceived level of milk and on fatigue. An improvement in the level of tiredness was observed by 83% of testers and up to 87.5% where they showed significant levels of fatigue during recruitment. This is evidenced by the signiﬁcant increase in scores from 7 to 10 and the drop in scores ≤ 4 versus before the cure (Figure 2).
The feeling of being less tired at the end of the treatment is associated with a better mood. The mood changed favourably in 68% of mothers overall. This effect is also more frequently reported by those who judged it bad when they were selected (87%).
Figure 2: How do you rate your level of fatigue?
A high satisfaction rate for mothers
After the first week of treatment, 9 out of 10 mothers say they are satisfied with Calmosine Breastfeeding, and this figure continues to increase slightly during the second week (Figure 3).
Figure 3: Testers Satisfaction Levels
The practicality and ease of use of the product thanks to the pod format was appreciated by all mothers. Note that this satisfaction is not dependent on the diﬃculty of breastfeeding, perceived fatigue or mood before the start of the treatment.
More than 9 out of 10 mothers are ready to recommend Calmosine Breastfeeding to a friend, within the first week of use. Over three-quarters (76.7%) would buy Calmosine Breastfeeding at the end of the first week of treatment and 81.7% after having tested it for two weeks. The mothers’ intentions regarding the recommendation and the purchase of the product following the treatment are, here again, independent of their initial characteristics/scores.
Almost unanimously, the herbal composition of Calmosine Breastfeeding was considered a real asset: 70% of mothers consider it very important and 25% consider it a “plus”.
On the other hand, the taste of Calmosine is its weak point: only a quarter of the testers (respectively 28.3% and 25% after the first and second treatment) took the product directly with the stick and found the taste pleasant. The majority of them have previously diluted the pods, most often in a glass of water (53.3% and 46.7%).
Calmosine Breastfeeding is a supplement to be drank daily by mum in the first few weeks after birth to help with milk production, as well as tiredness, stress and anxiety, all common feelings experienced when having new baby.
It is formulated with Passiflora, a plant belonging to the passifloraceae family traditionally used to soothe, relax and alleviate stress. Passiflora helps to restore calm, reduce tension and feelings of irritability due to nervous fatigue.
Fenugreek is a plant belonging to the fabaceae family which has long been known to improve lactation by helping to stimulate and maintain milk production. It has been used in certain cultures for many years for this purpose. Fenugreek also helps promote postnatal recovery.
Dog Rose Hip is part of the rosaceae family, used to fight the effects of fatigue. The dog rose hip helps support everyday vitality.
Biotin (Vitamin B8) contributes to the maintenance of normal skin and mucous membranes and last but not least, Magnesium helps to reduce tiredness and supports normal nervous system function.
For Calmosine Breastfeeding, we recommend drinking two sachets a day mixed in a large glass of water or juice. This can be at two separate times or in a bottle and drank continuously throughout the day.
None of the Calmosine range contains sugars alcohols or preservatives.
Certified organic (Breastfeeding also contains Biotin and magnesium)
Suitable for vegetarians and vegans
Out of stock